People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,193.00GBp
6:27am EDT
Change (% chg)

3.00p (+0.07%)
Prev Close
4,190.00p
Open
4,190.00p
Day's High
4,210.00p
Day's Low
4,180.50p
Volume
900,705
Avg. Vol
2,728,013
52-wk High
4,931.68p
52-wk Low
4,019.00p

Search Stocks

Pott, Jeffrey 

Mr. Jeffrey Pott is General Counsel of AstraZeneca Plc. Jeff was appointed General Counsel in January 2009 and has overall responsibility for all aspects of AstraZeneca’s Legal and IP function. He joined AstraZeneca in 1995 and has worked in various litigation roles, where he has had responsibility for IP, anti-trust and product liability litigation. Prior to joining AstraZeneca, he spent five years at the US legal firm Drinker Biddle and Reath LLP, where he specialised in pharmaceutical product liability litigation and anti-trust advice and litigation. He received his bachelor’s degree in political science from Wheaton College and his Juris Doctor Degree from Villanova University School of Law.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

540,000

Pascal Soriot

3,344,000

Marc Dunoyer

296,000

Ruud Dobber

--

Caroline Hempstead

--

Paul Hudson

--
As Of  30 Dec 2013
Search Stocks